Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Golgi Peptide Can Trigger Apoptosis

By LabMedica International staff writers
Posted on 26 Jan 2009
A team of cellular and molecular biologists have identified a peptide that is the smallest molecule found so far that can trigger the sequence of events leading to apoptosis (programmed cell death).

Investigators at the Albert Einstein College of Medicine (New York City, NY, USA) have been studying the role of intracellular organelles on apoptosis. More...
In the current study, they focused on the Golgi apparatus, the cell's main site for modification and distribution of proteins and other large molecules. The Golgi apparatus is a stack of membrane-bound vesicles that package macromolecules for transport elsewhere in the cell. The enzymatic or hormonal contents of lysosomes, peroxisomes, and secretory vesicles are packaged in membrane-bound vesicles at the periphery of the organelle.

The investigators reported in the January 16, 2009, issue of the Journal of Biological Chemistry (JBC) that a 205 amino acid protein fragment generated by cleavage of the Golgi's p115 protein could be further reduced to a 26 amino acid peptide, which retained the p115 protein's ability to trigger apoptosis. Onset of apoptosis required translocation of the active peptide from the cytoplasm to the nucleus of the cell.

Professor Dennis Shields, who died unexpectedly in December 2008, directed the research effort. "Dennis Shields was one of our most outstanding scientists," said Dr. E. Richard Stanley, chairman of developmental and molecular biology at the Albert Einstein College of Medicine. "His efforts to uncover fundamental mechanisms governing how cells work has led to new ways of thinking about apoptosis, in particular, how the Golgi regulates this process."

Related Links:

Albert Einstein College of Medicine




New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.